Prospective SPIRIT-HCM trial demonstrates broad gains over 12-month follow-up
The procedure is safe, but prepare for AF recurrence rates approaching 50%
Expert insights on managing HCM when debulking isn’t an option
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy